ArticleHarm reduction journal2025
Use of low-threshold naloxone boxes for opioid overdose prevention in a Midwestern US State: a public health program evaluation.
Article in Harm reduction journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionDespite reductions in overdose deaths reported nationally in 2025, overdose remains a leading cause of death in Michigan and the broader United States. Naloxone is a safe and highly effective opioid antagonist that can reverse opioid overdose, and community-based distribution to people at highest risk of overdose is a key overdose death prevention strategy.
methodsIn 2021, Harm Reduction Michigan (HRMI) launched an innovative naloxone box model to boost community-based naloxone distribution through publicly accessible, unlocked, outdoor naloxone boxes. To evaluate HRMI's naloxone box model, we conducted stakeholder interviews and analyzed secondary quantitative data about naloxone box stocking and placement.
resultsAs of December 2024, HRMI has placed 184 naloxone boxes in 85 jurisdictions within 47 Michigan counties, resulting in 24,428 doses of naloxone distributed from 2023 to 2024 alone. Naloxone boxes are prevalent in some, but not all, counties with high overdose death rates, suggesting the need for data-driven placement to support equitable access. However, stakeholders universally perceived the naloxone box model as impactful and crucial to saving lives, noting that naloxone boxes democratize naloxone distribution through their low-barrier, 24/7 availability and relative anonymity. They noted that amid persistent drug-related stigma, naloxone boxes create opportunities for productive conversations about overdose, drug use, and harm reduction in communities.
conclusionThese models are strengthened by partnership with non-traditional partners (such as restaurants or retail stores) who request to host boxes, along with meaningful involvement of people with lived experience of drug use, overdose, and interrelated conditions in box planning, implementation, and maintenance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.